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Studies of B lymphocytes at the nucleic acid level have confirmed the potential  for 
the expression of an extremely diverse antibody repertoire and have provided insights 
into the molecular processes involved in this expression  (1-7).  In addition,  studies at 
the  phenotypic  level  have  increased  our  understanding  of  the  mechanisms  that 
regulate  this  genetic  information  and  determine  the expression  of each of the  many 
antibody  permutations.  These  mechanisms  include  tolerance  induction  (8-14)  and 
antiidiotypic  suppression  (15,  16)  of developing  B  cell  clones,  as  well  as  idiotype- 
specific mechanisms that may be responsible for clonal expansion  (17,  18). 
Among the most striking  features  of the immune mechanism  is the extraordinary 
reproducibility  of repertoire  expression  (19-24).  Thus,  in  spite  of  the  extremely 
complex mechanisms available  for diversification  and clonotype selection,  repertoire 
sharing  appears  to  be  the  rule  among  genetically  identical  individuals.  This  is 
particularly  true  in  situations  where  the  repertoire  is  limited  such  as  in  genetically 
identical  frogs  (19),  bursectomized  chickens  (20),  and,  most  importantly,  neonatal 
mice  (21-24).  Additionally,  where  it  has been possible  to evaluate  the expression  of 
clonotypes that occur in high frequency, or even rare clonotypes that are idiotypically 
identifiable,  adult mice of the same strain apparently share repertoire  (25-33). 
To initiate an evaluation of the mechanisms, both genetic and regulatory, that may 
be  responsible  for  the  reproducible  acquisition  and  expression  of  the  antibody 
repertoire,  we have undertaken  to establish  highly specific idiotypic assays  that  can 
identify early neonatal clonotypes. This has been accomplished by producing hybri- 
domas with antibody-producing cells  derived  from dinitrophenyl  (DNp)l-responsive 
neonatal  B  cells.  The use of these monoclonal antibodies  and antiidiotypic reagents 
has confirmed several previously established basic tenants of neonatal responses (21). 
In addition, the availability of large quantities of monoclonal neonatal antibodies has 
enabled  a  careful  characterization  of neonatal  antibodies  in  terms  of their  physico- 
chemical  and  antigen-binding  properties.  Most  important,  the  availability  of anti- 
idiotypic assays for neonatal  antibodies  has enabled a  more precise definition  of the 
neonatal  DNP  specific  B  cell  repertoire  of BALB/c mice and  an  evaluation  of the 
expression  and control of these clonotypes, in  both  developing and  mature  mice, at 
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the level of clonal precursors and serum antibodies. These assays have permitted an 
evaluation  of  the  expression  of  these  clonotypes  during  the  lifetime  of  allotype 
allogeneic murine strains and F1 hybrids. 
Materials and Methods 
Animals.  Pregnant  BALB/c  mice  were  obtained  from  Ace  Animals, Philadelphia,  PA. 
Neonatal and adult BALB/c, B10.D2,  (BALB/c ×  B10.D2)FI, (BALB/c × A/J)FI, CB.20, and 
(BALB/c  ×  CB.20)F1  mice were obtained from  the colony of M.  P.  Cancro, University of 
Pennsylvania, or the colony of Scripps Clinic and Research  Foundation. New  Zealand red 
rabbits were obtained from Burley Ranch, Bonita, CA. 
Antigens.  Hemocyanin (Hy)  (Worthington Biochemicals, Freehold, N  J) and bovine serum 
albumin (BSA) (Calbiochem-Behring  Corp., San Diego, CA) were coupled to 2,4-DNP sulfonate 
(Eastman Laboratory and  Specialty Chemicals, Rochester,  NY)  using previously described 
methods  (8,  34).  The  unbound hapten was  removed by column chromatography  and  the 
substitution ratio of the coupled protein was determined. All haptenated proteins used in this 
study had a substitution ratio of ~ 10 mol of DNP/100,000 g of protein. 
Splenic Fragment System.  The splenic fragment system  has  been described in great  detail 
elsewhere  (21, 34). Briefly, limiting numbers of spleen cells (2  4 ×  106) obtained from neonatal 
or  adult  donors  were  injected into  lethally irradiated  BALB/c  adult  mice  that  had  been 
immunized by the intraperitoneal injection of 0.1 mg Hy 2 mo previously. The following day, 
the recipient spleen was removed asceptically and chopped into 1-mm cubes. These fragments 
were individually placed in culture and stimulated with DNP-Hy (10  -6 M  for DNP) for 3 d. 
The culture fluids were then changed and collected every 3 d and were assayed for anti-DNP 
antibody production on days 10 and 13. 
Tolerance susceptibility of B cells is assessed in this system by the addition of the tolerogen 
(DNP-BSA, 10  -6 M for DNP) to cultures for 24 h before the addition of the immunogen (DNP- 
Hy) (8,  12). 
Radioimmunoassay.  The solid-phase radioimmunoassay (RIA) has been previously described 
(21, 34, 35). Briefly, polyvinylchloride  plates (Dynatech Laboratories, Inc., Arlington, VA) were 
coated with DNP-BSA and blocked with 5% horse  serum in buffer containing 0.2 M  sodium 
phosphate pH 7.2 and 0.15 M sodium chloride (PBS). After washing, 20 ~1 of culture fluid or 
a dilution of hybridoma antibody or serum was added and allowed to incubate 2-4 h. After 
washing, the plates were incubated overnight with 125I-labeled rabbit antimouse Fab or class- 
specific reagents (courtesy  of M. P. Cancro). All 12~I-labeled  antibodies in this study, including 
the rabbit anti-mouse  reagents and the hybridoma antibodies used in the antiidiotype inhibition 
assay, were labeled by the method of Klinman and Howard (36). 
Transfer Fusion.  Transfer fusions were carried out by a  previously described modification 
(37) of the Kohler and Milstein (38) procedure for preparing hybridomas. The SP2/0 Agl4 
myeloma line (39) was obtained from the laboratory of R. H. Kennett, University of Pennsyl- 
vania. Lethally irradiated (800 rad) Hy-primed adult (BALB/c X A/J)F, mice were injected 
intravenously with 4 ×  106 neonatal BALB/c spleen cells on day 0. On day  1, the recipient 
mouse was intravenously injected with  100/~g of DNP-Hy in PBS. The spleen was removed 5 
d thereafter and was fused with myeloma cells at a  10:1 ratio of spleen to myeloma cells using 
an 8-min polyethylene glycol exposure.  The cells were then distributed into microtiter dishes in 
hypoxanthine, aminopterin, thymidine medium and wells with growth were assayed for anti- 
DNP antibody. Cells of positive wells were subcloned and grown in bulk culture and in ascites 
form  in  pristane  primed  BALB/c  mice.  The  H-2  haplotype  of hybridoma cell  lines was 
determined by treatment of the cells with either anti-H-2D or anti-H-2K antisera plus rabbit 
complement (40). 
Purification and Characterization of Anti-DNP Antibodies.  The anti-DNP antibodies were purified 
from ascites by passing clarified aseitic fluid over a DNP-BSA-Sepharose 4B column and eluting 
the anti-DNP antibodies with 0.5 M acetic acid (37). Association constants of purified antibodies 
or antibodies in ascitic fluid were determined by equilibrium dialysis by a  method that  has 
been described  previously (34, 37,  41).  The  isoelectric  point of hybridoma antibodies was 1172  CONTROL OF  NEONATAl, ANTIBODY  EXPRESSION 
determined by a sucrose density gradient isoelectric focusing (IEF) method that was previously 
shown to permit analysis of small amounts of IgM antibodies  (21,  42, 43). 
Production of Antiidiotype Antibodies.  Rabbits  were  injected  at  multiple sites subcutaneously 
with 3 mg purified antibody emulsified in complete Freund's  adjuvant.  The rabbits  were ear 
bled 20--30  d  after each of three bimonthly injections. The resulting serum was then absorbed 
extensively on Sepharose 4B coupled to a  BALB/c anti-DNP specific hybridoma  antibody of 
the same heavy chain and light chain class as well as Sepharose 4B coupled to normal routine 
immunoglobulin. 
Antiidiotype RIA.  The  idiotypic  composition  of  serum  and  monoclonal  antibodies  was 
assessed  by a  plate  binding competition assay  which  has  been  previously described  (30,  43). 
Serial dilutions  of each  rabbit  antiidiotype  serum  in  PBS were bound  directly to polyvinyl- 
chloride plates  at room temperature  for 4  h.  After blocking the wells with irrelevant protein, 
various dilutions of 125I-labeled  hybridoma  protein  to which  the antiidiotype was raised were 
added  and  the plates  were incubated  overnight at  37°C.  After determination  of the optimal 
antiidiotype and labeled idiotype dilutions, unlabeled idiotype or other hybridoma or myeloma 
proteins were used as competitors of the antiidiotype-idiotype reaction to assess its specificity. 
For determination of idiotype presence in monoclonal splenic fragment culture fluids, 20/*1 of 
culture fluid was added as the inhibitor. For determination of idiotype presence in mouse sera, 
20  #1  of various  dilutions  of mouse  sera  were  added  as  the  inhibitor.  Culture  fluids  were 
designated positive for the idiotype only if their inhibition of binding of the mSI-labeled idiotype 
to  the  antiidiotype  plate  was  equivalent  (+20~)  on  a  weight  basis  to  the  inhibition  by  the 
homologous  idiotype.  Final  dilutions  of  rabbit  antiidiotypes  used  were  ~10 -a.  Iodinated 
idiotype was used at between 2 and 5 ng/well. 
Results 
Obtaining Hybridomas by Adoptive Transfer Fusions.  Table I presents the frequencies of 
anti-DNP-producing  hybridomas when BALB/c  neonatal spleen cells were transferred 
into  irradiated,  Hy-primed  (BALB/c  X  A/J)F1  adults  and  stimulated  with  0.1  mg 
DNP-Hy  injected intravenously.  The use of F1  recipients enabled  a  demonstration  of 
the donor origin of the hybridomas  by virtue of the presence on their surface of H-2D 
haplotype  alloantigens  and  the absence  on their surface of H-2K  haplotype  alloanti- 
gens  as  determined  by  complement-mediated  cytotoxicity.  If no  neonatal  cells were 
transferred  to recipients, then no growing hybrids were obtained. When  neonatal cells 
alone were injected and antigen not given, occasional hybrids were obtained, but they 
did not secrete anti-DNP  antibody.  Injecting both neonatal cells and DNP-Hy  caused 
a  marked  increase  in  the  number  of growing hybrids  and  several of these  displayed 
anti-DNP  antibody activity. Of the 15 anti-DNP hybridomas obtained in this manner, 
2  have been subcloned  and  used  for further study. 
Characterization of Hybridoma Antibodies Derived  from Neonatal B Cells.  Table II presents 
TABLE  I 
Adoptive Transfer Fusions 
Number of  Number of cells*  Number of  anti-DNP-  injected  DNP-HY ir~jected  bybrids  specific hybrids 
0  100/~g  0  0 
4 X 10  ~  0  18  0 
4 X 10  (~  100 gg  107  13 
4 X 10  ~  I00/zg  41  2 
* 4 X 10  *~ cells were injected intravenously into irradiated (800 rad) tty-primed 
mice 24 h before antigen stimulation. Fusions were carried out 5 d thereafter 
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TABLE  II 
Characteristics of Two Neonatal Anti-DNP Hybridomas 
Hybridoma  Ig class*  Ko (4°C)~:  pl (:t: 0.05)§ 
TF2-36  /t, K  2.6 X  106 M -~  5.05 
TF2-76  #, f¢  6.0 ×  105 M -~  4.60 
* Immunoglobulin  heavy and  light  chain  composition  were  determined  by 
RIA (35). 
Binding  constants were  determined  by  equilibrium  dialysis at  4°C  (41). 
Binding by both antibodies extrapolated to 10 combining sites per molecule. 
§ pI were determined by microsucrose gradient IEF (42). 
Rabbit anti-TF2-36  Rabbit anti-TF2-76 
loo. L  ,~.,~5_  .,o;:~;~_ 
g  1'0  20 50  2 5  10  20  50 
Nanograms Inhibitor 
FZG.  I.  Specificity of rabbit antiidiotypic antisera. The relative inhibitory patterns of both homol- 
ogous and heterologous inhibitors in the competition RIA for the two antiidiotypic reagents. 
the  isotypes, hapten  binding  characteristics,  and  isoelectric points  (pI)  of the  two 
hybridoma  antibodies  derived  from  neonatal  B  cell  fusions.  Consistent  with  the 
neonatal origin of these antibodies, both express/z heavy chains. 
The hapten binding characteristics of these two monoclonal antibodies are inter- 
esting  in  several  respects.  As  will  be  demonstrated  below,  the  TF2-36 hybridoma 
antibody is indistinguishable from a large proportion of very early neonatal anti-DNP 
antibodies.  Interestingly, this monoclonal antibody displays an association constant 
for  the  DNP  haptenic  determinant  that  is  slightly  higher  than  the  average  of 
association constants displayed by monoclonal antibodies derived from normal adult 
donors  (34).  This  finding  contrasts  with  evidence from  other laboratories  (44,  45) 
suggesting relatively low affinities of early neonatal anti-DNP antibodies. The TF2- 
76 monoclonal antibody displays a somewhat lower affinity than TF2-36 but is also 
well  within  the  range of affinities of normal  adult  primary  monoclonal antibodies 
(34). 
The TF2-36 hybridoma antibody displays a  pI of 5.05, which  is one of the three 
pI  characteristic  of a  majority  of monoclonal  anti-DNP  antibodies  derived  from 
BALB/c mice during the first 5 d  after birth  (21).  It would appear,  therefore, that 
antibodies  of this  idiotype comprise  at  least  a  subset  of early  neonatal  anti-DNP 
antibodies previously identified as displaying a pI in this range. 
Antiidiotypic  Analysis  of Hybridoma Antibodies Derived from  Neonatal B  Cells.  Fig.  1 
depicts the reactivity of the two adsorbed rabbit antiidiotypic antisera, anti-TF2-36 
and anti-TF2-76, in a  solid-phase competition RIA.  Each was tested against  a  large 
panel of immunoglobulins including other anti-DNP neonatal antibodies, as well as 
MOPC-460 and MOPC-315,  two anti-DNP-reactive myeloma proteins. Both of the 
antiidiotypes were completely specific for the immunizing antibody. 
A  particularly important feature of these antiidiotype competition assays is their 
extreme sensitivity. Each assay is set up such that  50% inhibition of the binding of 
2-5  ng  of  125I-labeled  idiotype  is  achieved  by  2-5  ng  of unlabeled  homologous 1174  CONTROL  OF  NEONATAL  ANTIBODY  EXPRESSION 
competitor. The stoichiometry and sensitivity is a  critical feature of an antiidiotype 
assay used to screen monoclonal antibodies derived from splenic fragment cultures for 
idiotype  since  culture  fluids  used  as  competitors  for  the  antiidiotype  most  often 
contained <10 ng of anti-DNP antibody. 
Idiotypic Analysis  of Monoclonal Anti-DNP Responses of B  Cells from  BALB/c  Mice  at 
Various Ages.  A  survey of anti-DNP  antibodies  derived  from BALB/c  spleen  cells 
from mice ranging  in  age fi'om  1 d  after birth  to 8  wk was done  to  determine  the 
representation  of these two idiotypes among the various  B cell  populations.  This is 
depicted  graphically  in  Fig.  2.  The  temporal  pattern  represented  by TF2-36  was 
expected  from earlier  studies  of the  neonatal  repertoire  (21),  in  that  this  neonatal 
idiotype is  found  expressed by a  fairly high  proportion  of the  anti-DNP  specific B 
cells during  the  first  few days after birth  and subsequently  decreases.  The idiotype 
represented by TF2-36 comprises  14% of the anti-DNP  antibodies  from spleen cells 
3-4  d  after  birth,  falls  to  ~2%  7-8  d  after  birth,  and  remains  at  this  level  into 
adulthood. 
To confirm  the  homology of the  TF2-36-positive  monoclonal  antibodies  derived 
from  fragment  culture  to  the  hybridoma  antibody,  IEF  analysis  was  carried  out. 
Seven  IgM antibodies  that  displayed  the TF2-36  idiotype derived  from both adult 
and neonatal B cells were subjected to microsucrose density gradient  IEF. All of the 
antibodies positive for the TF2-36 idiotype showed an IEF spectrum indistinguishable 
from TF2-36. Thus, by two criteria, idiotype analysis and IEF, antibodies bearing the 
TF2-36 idiotype represent a  predominant  anti-DNP specificity of the early neonatal 
BALB/c  repertoire.  Since  the  previous studies  of the  early BALB/c  neonatal  anti- 
DNP repertoire showed  IgM monoclonal antibodies with an isoelectric point  in  the 
range of 5.05 represented ~35-45% of all anti-DNP antibodies (21), it may be assumed 
that  at  least  one  other  anti-DNP  antibody  bearing  a  different  idiotype  migrated 
indistinguishably from TF2-36 in IEF. 
The idiotype represented by TF2-76 showed quite a  different pattern of temporal 
expression.  This  idiotype  was  present  in  <1%  of anti-DNP  antibodies  secreted  by 
spleen cells obtained during the first few days after birth. By days 7  8, the proportion 
of anti-DNP  antibodies  bearing  this  idiotype  began  to  rise  and  reached  a  peak of 
almost 7% on days 12-13. 
Confirmation of the  Temporal Acquisition of Clonotypes by the  Tolerance Marker.  Several 
°I 
~  15 
1.2  3-4  7-8  12-13  #AuIt 
Days Afler Birth 
Fie.  2.  The temporal expression of idiotype. The temporal expression of the TF2-36 (liB) and TF2- 
76  (K]) idiotypes  among monoclonal  anti-DNP  antibodies  derived  from  BALB/c  spleen cells of 
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years ago, it was demonstrated that phosphorylcholine (PC)-responsive B cells appear 
in  the  splenic  B  cell  repertoire  several  days  later  in  development  than  do  B  cells 
responsive to DNP (23). This finding was confirmed by the fact that the majority of 
B cells responsive to PC are immature by the criteria of their susceptibility to in vitro 
tolerance induction as late as 10 d after birth, a  time when the vast majority of B cells 
responsive to DNP are sufficiently mature to be tolerance-resistant  (12). This finding 
not only confirmed the relatively late  developmental  acquisition  and  maturation  of 
PC responsive B cells,  but  also established  the principle  that  tolerance susceptibility 
is a  characteristic of the developmental status of individual  B cell clones, rather than 
the  developmental  status  of the  animal  as  a  whole.  The  finding  that  the  TF2-76 
idiotype  is  displayed  primarily  by  B  cells  that  arise  several  days  later  than  those 
bearing the TF2-36 idiotype provided an opportunity to confirm these concepts in a 
system in which both mature and immature B cells would be responding to the same 
haptenic  determinant.  To determine  if B cells bearing the TF2-76 idiotype actually 
represented a B cell population that matures a week or so later in splenic development 
than  cells  bearing  the  TF2-36  idiotype,  in  vitro  tolerance  susceptibility  of TF2-76- 
and  TF2-36-bearing  day  7  BALB/c  B  cells  was  assessed  (Table  III).  While  the 
majority  of DNP-specific day  7 splenic  B  cells  including  those  bearing  the TF2-36 
idiotype  were  unaffected  by  the  tolerization  regimen,  those  bearing  the  TF2-76 
idiotype  were  significantly  (P  =  0.01)  decreased.  Thus,  it  appears  that  TF2-76 
represents a  relatively late-appearing and -maturing B cell clonotype. 
The Distribution  of BALB/c Neonatal Clonotypes in Other Murine Strains.  The idiotypic 
reactivity of monoclonal anti-DNP antibodies  derived from B cells of various murine 
strains in splenic fragment culture is shown in Table IV. Represented are antibodies 
derived  from  spleen  cells  during  the  1st  and  2rid  wk  after  birth,  as  well  as  those 
obtained  from adult  mice of the BALB/c, CB.20, and  (BALB/c ×  CB.20)F1 strains. 
It  can  be  seen  that  monoclonal  antibodies  bearing  either  the  TF2-36  or  TF2-76 
idiotypes are not  present  in high  frequency at  any time during  the  development  of 
mice  bearing  the  Igh  b  allotype-idiotype  locus.  Thus,  as  with  the  vast  majority  of 
identifiable idiotypes that have been found to predominate adult repertoires  (25-31), 
at  least  the  magnitude  of  neonatal  idiotype  expression  within  the  repertoire  is 
polymorphic,  and  this  expression  links  to  the  Igh locus.  This  finding  confirms  the 
polymorphism of immunogiobulin variable region expression and (in the case of TF2- 
TABLE  III 
Effect of In  Vitro Exposure to DNP-BSA on the Frequency  of Monoclonal Anti-DNP Antibody 
Responses and Their Idiotype Distribution 
Total number  Tolerogen  DNP-specific  ]diotype-positive§ 
cells per 106  Spleen cell donor  spleen cells  (10 6 M  splenic B  transferred*  DNP-BSA)  cells:~  TF2-36  TF2-76 
BALB/c d 7  90 ×  106  -  60.6  2.2  4.4 
BALB/c d 7  66 x  106  +  60.2  2.6  1.311 
* Pooled data from four experiments. 
~: Figures given are corrected for homing and cloning efficiency of 4% for neonatal splenic B cells (8, 21). 
§ A total of 137 monoclonal antibodies derived from day 7 spleen cells not exposed to tolerogen and 75 
derived from day 7 spleen cells exposed to tolerogen were analyzed. 
11 Using 2 × 2 contingency table X  2 analysis = 6.16, P = 0.01. 1176  CONTROL  OF NEONATAL  ANTIBODY  EXPRESSION 
TABLE  IV 
Idiotypic Reactivity of Monoclonal Anti-DNP Antibodies Derived  from Splenic Fragment Cultures 
Total num-  Percent positive 
ber of mono- 
B cell donor  lgh locus  Age  clonal anti- 
TF2-36"  TF2-76  bodies tested 
BALB/c  a 
d 
1 6  568  13.5  1A 
7-13  227  1.8  4.8 
Adult  196  2.0  2.5 
CB.20  b  1 6  276  1.1  0.7 
7  13  198  0.5  0.5 
Adult  108  0  0 
(BALB/c x  GB.20)F1  a/b  1  6  64  10.9  1.6 
7  11-1  92  1.1  3.3 
Adult  108  0.9  0.9 
* Idiotype analyses were carried by competitive inhibition  of plate binding using individual monoclonal 
antibodies.  Antibodies  were  considered  positive  for  idiotype if inhibition  of binding of 12SI-labeled 
homologous idiotype was +20% that of unlabeled homologous idiotype on a weight basis. 
36)  extends  it  to  the  very  earliest  of  expressed  clonotypes.  Also,  consistent  with 
previous studies of several predominant idiotypes (17,  18, 46-53), antibodies bearing 
idiotypes indistinguishable from the two BALB/c neonatal clonotypes can be observed 
at  low frequency  in strains in which  they do not predominate.  Thus  clones bearing 
both  the TF2-76  and TF2-36  idiotypes have  been  found  in strains bearing the Igh  b 
heavy  chain  locus.  This  finding  was  confirmed  by  an  analysis  of 95  monoclonal 
antibodies derived from  B10.D2  neonates  in which  we found  a  total of three mono- 
clonal antibodies that expressed the TF2-36 idiotype and one that expressed the TF2- 
76  idiotype. Although  Igh  b neonates  express  these clonotypes, they  are exceedingly 
rare in adults. In an analysis of 108  monoclonal antibodies derived from CB.20 adult 
spleen  cells and  72  monoclonal  antibodies  derived  from  B10.D2  adult  spleen  cells 
only, one  antibody  bore  the  TF2-36  idiotype, and  none  bore  the  TF2-76  idiotype. 
Since  it  must  be  assumed  that  antibodies derived  from  strains  differing in  the  Igh 
locus would  focus at  different pI, the identity of monoclonal antibodies bearing the 
TF2-36  and  TF2-76  idiotypes derived from  Igh  b strains could  not  be confirmed by 
IEF. 
Also shown  in  Table  IV  is  the  analysis of the expression of the  two  idiotypes in 
neonates and adults of F1 hybrids constructed between BALB/c and  CB.20  parents. 
It  can  be  seen  that  both  clonotypes are expressed  in  a  temporal  fashion  consistent 
with their expression in the BALB/c parent. Similarly, in an analysis of 96 monoclonal 
antibodies  derived  from  l-6-d-old  (BALB/c  ×  B10.D2)F1  neonates,  10  antibodies 
displayed the TF2-36  idiotype. Thus  the expression of these two  neonatal  idiotypes 
would appear to be consistent with codominant expression of variable region specific- 
ities. While codominant  expression  of variable region specificities has  been  demon- 
strated for clonotypes that predominate in adult repertoires (26-29), previous reports 
have indicated that  the temporal expression of repertoire may differ between  F1 and 
parental strains (51). 
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TABLE V 
Idiotypic Reactivity of Anti-DNP Antisera 
Anti-DNP  Strain  Igh  Immunization  antibody* 
Inhibition:~  of 
Anti-  Anti- 
TF2-36  TF2-76 
mg/ml 
BALB/c  a  1  o DNP-HY§  1.2  6  3 
2  ° DNP-ItYI[  10.3  15  10 
CB.20  b  1  ° DNP-HY  0.7  <1  <1 
2  ° DNP-ttY  8. l  <1  <1 
B10.D2  b  l ° DNP-ttY  0.9  <1  <1 
2  ° DNP-HY  9.6  <1  <1 
(BALB/c x B 10.D2)FI  a/b  1Q DNP-ItY  1.8  3  <l 
2  ° DNP-ttY  12.5  12  4 
* Values from pooled serum of five mice determined by RIA. 
:~ Percent inhibition =  [(nmnber of counts bound in well containing l/p,I normal serum) -- (number of 
counts bound in well containing 1/bd immune serum)l/[number of counts bound in well containing l ~1 
normal serum]. 
§ Serum taken 10 days after 100 #g DNP-HY in complete Freund's adjuvant injected intraperitoneally. 
II Serum taken 10 d after second DNP-HY injection (30 d after la). 
at the monoclonal level for the expression of these neonatal anti-DNP idiotypes were 
further examined at  the level of anti-DNP serum antibody. Adult mice were immu- 
nized with  DNP-Hy and serum was  collected during both  primary and secondary 
responses. These sera were then evaluated for their content of anti-DNP antibodies as 
well  as  their  ability  to  compete  in  the  antiidiotype  RIA  (Table  V).  Since  no 
determination of idiotype sharing could be made on a  weight basis, as was done for 
monoclonal antibodies, the percent inhibition of 125I-labeled idiotype binding to the 
antiidiotype plate  by  1 #!  of  immune serum  was  calculated.  Only  BALB/c  and 
(BALB/c ×  B10.D2)F1 anti-DNP antisera contained detectable amounts of antibodies 
either  identical or  cross-reactive  with  the  two  neonatal anti-DNP antibodies. The 
small amounts of inhibition obtained, even with BALB/c anti-DNP antisera, indicate 
a  very low concentration (~1  btg/ml in secondary sera)  of antibodies bearing these 
idiotypes in serum. Thus, while in the  BALB/c and F1 adults these clonotypes are 
expressed  by  1-2%  of DNP-specific  precursor  cells,  antibodies derived  from  these 
precursors would appear to represent no more than  1/10,000 of the total anti-DNP 
serum antibody response. The inordinately low expression of these antibodies in adult 
immune serum is similar to disparities in serum antibody vs. precursor cell frequency 
for the TEPC-15 idiotype in certain strains (47)  and presumably reflects the multi- 
factorial control of serum antibody expression. 
Discussion 
Although mechanisms have been defined that can readily account for an extraor- 
dinarily  diverse  antibody  repertoire  (1-7),  previous  studies  have  indicated  that 
neonatal mice  have  a  relatively limited repertoire  and  that  repertoire  diversity is 
gradually acquired in a  highly reproducible manner within an inbred murine strain 
(21-24). To investigate the characteristics of early neonatal antibodies and probe the 
mechanisms that  may be responsible for repertoire acquisition, we have established 
two hybridoma cell lines derived from neonatal B cells antigenically stimulated in an 1178  CONTROI,  OF  NEONATAL ANTIBODY EXPRESSION 
irradiated  adoptive host.  In this case, the adoptive host  strategem was necessary to 
provide  carrier-primed  T  cells,  which  have  been  shown  previously  to  facilitate 
responses of neonatal B cells. 
The  availability  of  well-defined  neonatal  hybridoma  antibodies  and  sensitive 
antiidiotypic assays for their identification has enabled us to refine and extend earlier 
studies of the developmental acquisition of the anti-DNP repertoire in BALB/c mice. 
One of the two IgM hybridoma antibodies, TF2-36, is indistinguishable by idiotypic 
and IEF analyses from the monoclonal antibody product of 10-15% of DNP-specific 
BALB/c B cells during the first  few days after birth.  The finding of an identifiable 
clonotype that is present in high frequency in the B cell population of early neonates 
of a given strain confirms previous indications that early neonatal repertoire expression 
is  both  restricted  and  reproducible.  In  particular,  cells  of  the  TF2-36  clonotype 
represent  l  in  104-105 of all  BALB/c B cells during the first  few days after birth.  In 
comparison  with  previous  findings  concerning  the  IEF spectrum  of early neonatal 
anti-DNP  antibodies  (21),  clones  of the  TF2-36  clonotype represent  approximately 
one-third of all clones that isofocus at a pI of ~5.05. Thus, careful analysis of repertoire 
by both  idiotypic and  IEF analyses should  ultimately  yield  a  more comprehensive 
overview of the exact extent of repertoire diversity than did analysis by IEF alone. 
The availability of idiotypic analysis of the expression of the TF2-36 clonotype has 
also  permitted  a  previously  unavailable  assessment  of the  fate  of a  predominant 
neonatal clonotype during the course of murine development. The findings indicate 
that the relative representation orB cells bearing this clonotype wanes rapidly towards 
the end  of the  first  week of neonatal  development.  However, B cells of the TF2-36 
clonotype continue to be expressed even in  BALB/c adults.  Thus, B cells of a  given 
clonotype  can  be  expressed  continuously,  and  early  neonatal  expression  neither 
precludes adult expression, nor does it necessarily correlate with predominant expres- 
sion in the adult repertoire. 
The  developmental  acquisition  of  B  cells  expressing  the  TF2-76  clonotype  is 
strikingly different from that of B cells expressing the TF2-36 clonotype. The temporal 
expression of this clonotype would seem much more similar to certain anti-influenza 
hemagglutinin  specificities,  in  that  its proportional  representation  within  the B cell 
repertoire reaches a  maximum towards the end of the 2nd  wk after birth  (24). The 
identification of a  clonotype that is apparently expressed in all BALB/c neonates in 
high  frequency  as  late  as  2  wk  after  birth  confirms  the  conclusion  that  repertoire 
expression is highly patterned and reproducible within genetically identical  individ- 
uals,  even  at  a  developmental  stage  wherein  the  entire  repertoire  includes  >106 
clonotypes  (24).  As  with  TF2-36,  B  cells  of the  TF2-76  clonotype  continue  to  be 
expressed  into  adulthood  in  high  numbers,  although  they  represent  but  a  small 
proportion of the highly diversified adult  repertoire. Additionally, the relatively late 
acquisition  of B  cells  of the  TF2-76  clonotype  has  been  verified  by  the  relative 
susceptibility to tolerance of cells bearing this clonotype in the spleen  7 d after birth. 
The majority of DNP-specific B cells present  at  that  time, including  13 cells of the 
TF2-36 clonotype, are resistant to in vitro tolerance induction. 
The availability of antiidiotypic clonotype identification also provides a  means to 
compare the expression of given clonotypes within the B cell repertoire of disparate 
murine strains.  In the past, it has been the general case that clonotypes and families 
of clonotypes that can be identified in one strain are often either absent or present in KATHLEEN A.  DENIS AND NORMAN R.  KLINMAN  1179 
much lower frequencies in other murine strains, particularly strains that differ in the 
Ig heavy chain gene locus (25-33), and, where appropriate, the light chain gene locus 
(54).  In the majority of cases, such disparities  appear to be not  absolute but rather 
quantitative (17,  18, 46-50). However, with rare exceptions (53), it remains unknown 
whether  indistinguishable  clonotypes present  in  two distinct  strains are completely 
identical at the amino-acid sequence level, and whether genes expressing equivalent 
clonotypes in different strains are actually alleles of one another. The findings in this 
paper extend  these  comparisons  to  the  control  of clonotype expression  in  distinct 
strains at the earliest times in the neonatal development of the B cell repertoire. The 
findings indicate that for both the TF2-36 early clonotype and TF2-76 later clonotype, 
high  frequency  and  temporal appearance associate with  the  Ig heavy chain  locus. 
Both  expressions  occur  in  F1  progeny  of  Igh  differing  parentals,  thus  implying 
codominant  expression in the temporal appearance of predominant  neonatal clono- 
types. 
It is important to note that antibodies of both clonotypes can be identified, albeit 
at  very low frequency, in strains homozygous for the Igh  b heavy chain  locus. Thus, 
these clones would appear to fall into the category of those for which polymorphism 
is not  absolute but rather a  function of magnitude of expression  (17,  18,  32, 46-50). 
The infrequent but clear-cut expression of both the TF2-36 and TF2-76 clonotypes in 
CB.20 and B10.D2  neonates  (and the early low expression of TF2-76 in BALB/c as 
well)  may place these clonotypes in  the category previously referred to as "sporadic 
neonatal clonotypes" (21).  Such infrequently recurring clonotypes may represent the 
earliest expression of relatively late arising clones that would be sparsely represented 
in the very early neonatal  repertoire, such as TF2-76 during the first 4 d  of BALB/c 
neonatal  development.  Alternatively,  such  clonotypes  may,  for some reason,  never 
achieve the clonal expansion characteristic of the more predominant clonotypes. 
It  is  interesting  to note  that  both TF2-76  and  TF2-36  are extremely rare in  the 
mature adult repertoire of Igh  u mice. The paucity of this specificity in the repertoire 
of adult  Igh  b mice is consistent  with  the  lack of any detectable TF2-36 or TF2-76 
antibodies  in  the  immune  serum  of mice of these  strains.  Thus,  in  the  context  of 
expression in the adult serum repertoire, these two markers may appear to represent 
clonotypes  whose  expression  is  absolutely  polymorphic  between  these  strains.  The 
reproducible expression of B cells of these clonotypes in the early neonatal develop- 
ment of Igh  b mice, however, contradicts the absoluteness of such apparent polymor- 
phisms. Thus, both gene cloning analysis and developmental analysis may be necessary 
before any conclusions can be reached about whether the potential for the expression 
of a  given clonotype is  truly  missing in  certain  murine  strains,  or concluding  that 
given clonotypes are "private" (55)  to an  individual  and thus  the likely product  of 
random  somatic  events  rather  than  "germ  line"  expressions.  This  reservation  is 
consistent with recent findings wherein antiidiotypic selection revealed the potential 
for expression of clonotypes that otherwise had been assumed to be absent  in given 
murine strains  (17,  18)  as well as careful analyses which  have shown  that  even low 
frequency clonotypes can be expressed throughout a strain (32, 33). 
Summary 
Two  hybridoma  cell  lines  were  established  with  B  cells  derived  from  neonatal 
BALB/c spleen  cells.  The anti-dinitrophenyl  (DNP)  antibodies  derived  from these 1180  CONTROL  OF' NEONATAL  ANTIBODY  EXPRESSION 
lines were characterized with  respect to their isotype, affinity, and  isoelectric point. 
Antiidiotypic reagents were prepared that permit an analysis of the representation of 
antibodies sharing idiotype with these two hybridomas in the developing and mature 
B cell pool of BALB/c mice (Igh") and other murine strains. One of the two antibodies, 
TF2-36,  was  found  to  be  indistinguishable  from  14%  of  anti-DNP  monoclonal 
antibodies derived in fragment culture from spleen cells of 1-4-d-old BALB/c donors. 
B cells expressing this idiotype were found to represent ~2% of the anti-DNP-specific 
repertoire after the  1st wk of neonatal development and into adulthood. The second 
hybridoma antibody, TF2-76, was found to be expressed at very low levels during the 
first several days of neonatal development;  however,  B  cells expressing this idiotype 
increased in frequency during the 2nd wk of neonatal development representing 7% 
of all DNP-responsive B cells 12-13 d  after birth. The proportion of B cells expressing 
this idiotype also decreased to ~2% in adults. The relatively late appearance of B cells 
bearing this idiotype was confirmed by their susceptibility to tolerance induction after 
the 1st wk of neonatal development. Both  the early neonatal clonotype, TF2-36, and 
the late neonatal antibody clonotype, TF2-76, were found to be expressed in a similar 
fashion  in  Fa  mice  constructed  between  Igh  a  and  Igh  b  parentals,  but  both  were 
expressed at  very low levels during the development of Igh  b mice. Thus,  the control 
of the magnitude of expression of these neonatal clonotypes appears to be associated 
with the Igh locus. 
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Received for publication 22 November 1982. 
References 
1.  Sakano,  H.,  K  Huppi,  G.  Henrich,  and  S. Tonegawa.  1979. Sequences  at  the somalic 
recombination sites of immunoglobulin light chain genes. Nature (Lond.).  280:288. 
2.  Max, E., T. Seidman, and P. Leder.  1979. Sequences of five potential recombination sites 
encoded close to an immunoglobulin kappa constant region gene. Proc. NatL Acad. SoL  USA. 
76:3450. 
3.  Corey, S., and J. M. Adams. 1980. Deletions are associated with somatic rearrangement of 
immunoglobulin heavy chain genes. Cell  19:37. 
4.  Weigert, M., M. Gatmaitan, E. Loh, J.  Schilling, and L. Hood.  1978. Rearrangement of 
genetic information may produce immunoglobulin diversity. Nature  (Lond.). 276:785. 
5.  Rabbitts, T. H., G. Matthyssens, and P. H. Hamlyn. 1980. Contribution ofimmunoglobulin 
heavy-chain variable region genes to antibody diversity. Nature  (Lond.).  284:238. 
6.  Selsing, E., and U. Storb. 1981. Somatic mutation of immunoglobulin light chain variable 
region genes. Cell 25:47. 
7.  Crews, S.,J. Griffin, H. Huang, K. Calame, and L. Hood. 1981. A single VH gene segment 
encodes the immune response to phosphorylcholine: somatic mutation is correlated with 
the class of the antibody. Cell 25:59. 
8.  Metcalf, E. S., and N. R. Klinman.  1976. In vitro tolerance induction of neonatal routine B 
cells.J. Exp.  Med.  143:1327. 
9.  Nossal,  G. J.  V.,  and  B.  L.  Pike.  1975. Evidence  for  the  clonal  abortion  theory  of B 
lymphocyte tolerance.j  r. Exp. Med.  141:904. 
10.  Stocker, J. W.  1977. Tolerance induction in maturing B cells. Immunology. 32:282. 
11.  Cambier, J. C.,J. R. Kettman, E. S. Vitteta, andJ. W. Uhr. 1976. Differential susceptibility KATHLEEN  A.  DENIS AND NORMAN  R.  KLINMAN  1181 
of neonatal and adult murine spleen cells to in vitro induction of B cell tolerance. J. Exp. 
Med.  144:293. 
12.  Metcalf,  E.  S.,  N.  H.  Sigal, and  N.  R.  Klinman. 1977. In vitro tolerance induction of 
neonatal murine B cells  as a  probe for the study of B cell  diversification. J.  Exp.  Med. 
145:1382. 
13.  Klinman, N. R., A. F. Schrater, and D. H. Katz.  1981. Immature B cells as the target for 
in vivo tolerance induction.J, hnmunol.  126:1970. 
14.  Etlinger, H. M., and J. M. Chiller. 1979. Maturation of the lymphoid system.  I. Induction 
of tolerance in neonates with a  T  dependent antigen that  is an obligate immunogen in 
adults. J. Immunol. 122:2558. 
15.  Accolla, R.  S.,  P. J.  Gearhart,  N.  H.  Sigal,  M.  P.  Cancro, and  N.  R.  Klinman. 1977. 
Idiotype-specific neonatal  suppression  of  phosphorylcholine-responsive B  cells.  Eur. J. 
Immunol. 7:876. 
16.  Kohler, H., D.  Kaplan, R. Kaplan, J.  Fung, and J. Q uintans. 1979. Ontogeny of clonal 
dominance. In  Cells of Immunoglobulin Synthesis. B.  Pernis and  H. J.  Vogel, editors. 
Academic Press, Inc., New York.  357-369. 
17.  Bona, C.  A.,  E.  Heber-Katz, and W.  E.  Paul.  1981. Idiotype-antiidiotype regulation. I. 
Immunization  with a levan-binding  myeloma protein leads to the appearance of auto-anti- 
(anti-idiotype) antibodies and to the activation of silent clones.J. Exp.  Med.  153:951. 
18.  Hiernaux, J., C. Bona, and P. J. Baker.  1981. Neonatal treatment with low doses of anti- 
idiotypic antibody leads to the expression of a silent clone.J. Exp.  Med. 153:1004. 
19.  Du Pasquier, L., and M. R. Wabl. 1978. Antibody diversity in amphibians: inheritance of 
isoelectric  focusing antibody patterns in isogenic frogs. Eur. J. Immunol. 6:428. 
20.  Huang,  H.  V.,  and  W.  J.  Dreyer.  1978. Bursectomy  in  ovo  blocks  the  generation of 
immunoglobulin  diversity.  J. hnmunol. 232:1738. 
21.  Klinman, N. R., and J. L. Press.  1975. The characterization of the B cell repertoire specific 
for the DNP and TNP determinants in neonatal BALB/c mice.J. Exp.  Med. 141:1133. 
22.  Fernandez, C., and G. Moiler.  1978. Immunological unresponsiveness to native dextran 
B512  in young animals of dextran high responder strains is due to  lack of Ig receptor 
expression.J. Exp.  Med. 147:645. 
23.  Sigal, N.  H., P. J. Gearhart, J.  L. Press, and N. R. Klinman. 1976. Late acquisition of a 
germ line antibody specificity.  Nature (Lond.).  259:51. 
24.  Cancro, M. P., D. E. Wylie, W. Gerhard, and N. R. Klinman. 1979. Patterned acquisition 
of the  antibody repertoire:  diversity of the  hemagglutinin-specific B  cell  repertoire  in 
neonatal BALB/c mice. Proc. Natl. Acad. Sci. USA.  76:6577. 
25.  Lieberman, R., M. Potter, E. B. Mushinski, W. Humphrey and S. Rudikoff. 1974. Genetics 
of a  new  IgVH  (T15  idiotype)  marker  in  the  mouse  regulating natural  antibody to 
phosphorylcholine.J. Exp.  Med. 139:983. 
26.  Blomherg, B., W. R. Geckeler,  and M. Weigert. 1972. Genetics of the antibody response to 
dextran in mice. Science (Wash. DC).  177:178. 
27.  Makela, O., and K. Karjalainen. 1977. Inherited immunoglobulin  idiotypes of the mouse. 
Immunol. Rev. 34:119. 
28.  Nisonoff, A., and S.-T. Ju.  1976. Studies of a cross-reactive idiotype associated with anti-p- 
phenylarsonate antibodies of A/J mice. Ann. Immunol. (Paris).  127C:347. 
29.  Eichmann, K.  1975. Genetic control of antibody specificity in the mouse. Imrnunogenetics. 
2:491. 
30.  Gearhart, P. J., N.  Sigal, and N.  R.  Klinman. 1975. Heterogeneity of the BALB/c anti- 
phosphorylcholine antibody response at the precursor cell level.J. Exp.  Med. 141:56. 
31.  Reth, M., T. Imanishi-Kari and K. Rajewski.  1979. Analysis of the repertoire of anti-NP 
antibodies in C57BL/6 mice by cell fusion. II. Characterization ofidiotypes by monoclonal 
anti-idiotype antibodies. Eur. J. Imrnunol. 9:1004. 1182  CONTROL  OF  NEONATAL ANTIBODY EXPRESSION 
32.  Marshak-Rothstein, A., J.  D.  Benedetto, R.  L.  Kirsch, and M.  L.  Gefter.  1980. Unique 
determinants associated  with  hybridoma proteins  expressing  a  cross-reactive  idiotype: 
frequency among individual immune sera.J. Immunol. 125:1987. 
33.  Bloor, A. G., Y.-H. Jou, C. Hoeplinger, j. Gartner, G. L. Mayers, and R. B. Bankert. 1982. 
Hapten-specific B cell repertoire probed by hybridoma technology: selection and charac- 
terization of representative clonotypes from  the  antibody-forming cell  pool. J.  Immunol. 
128:1443. 
34.  Klinman, N. R.  1972. The mechanism of antigenic stimulation of primary and secondary 
clonal precursor cells, d  r. Exp.  Med. 136:241. 
35.  Pierce, S. K., and N. R. Klinman. 1977. Antibody-specific immunoregulation.dr. Exp. ivied. 
146:509. 
36.  Klinman, D.  M.,  and J.  C.  Howard.  1980. Protein  iodination suitable  for  labeling 
hybridoma antibodies. In Monoclonal Antibodies, R. H. Kennett, T. J. McKearn, and K. 
B. Bechtol,  editors.  Plenum Publishing Corp., New York. 401-402. 
37.  Liu, F.-T., J.  W. Bohn, E.  L.  Ferry, H.  Yamamoto, C.  Molinaro, L. A. Sherman, N.  R. 
Klinman, and  D.  H.  Katz.  1980. Monoclonal  DNP-specific  murine  IgE. dr.  Immunol. 
124:2728. 
38.  Kohler, G., and C. Milstein. 1975. Continuous cultures of fused cells secreting antibody of 
predefined specificity.  Nature (Lond.).  256:495. 
39.  Schulman, M., C. D. Wilde, and G. Kohler. 1978. Introduction and derivation of the SP2/ 
0-Agi4 cell line for fusion_ Nature (Lond.).  276:269. 
40.  Katz, D. H., B. J. Skidmore, L. R. Katz, and C. A. Bogowitz.  1978. Adaptive differentiation 
of murine lymphocytes. I.  Both  T  and B lymphocytes differentiating in F1 --~ parental 
chimeras manifest preferential cooperative activity for partner lymphocytes derived from 
the same parental type corresponding to the chimeric host.dr. Exp.  ivied  148:727. 
41.  Jaton, J.-C., N.  R. Klinman, D. Givol, and M. Sela.  1968. Recovery of antibody activity 
upon  reoxidation of completely reduced  polyalanyl heavy chain and  its  FD  fragment 
derived from anti-2,4-dinitrophenyl  antibody. Biochemistry. 7:4185. 
42.  Press, J. L., and N. R. Klinman. 1973. Isoelectric  analysis of neonatal monofocal antibody. 
Immunochemistry. 6:621. 
43.  Owen, J.  A., N.  H.  Sigal,  and N.  R.  Klinman. 1982. Heterogeneity of the BALB/c IgM 
anti-phosphorylcholine  antibody response.  Nature (Lond.).  295:347. 
44.  Goidl, E. A., and G. W. Siskind. 1974. Ontogeny of B lymphocyte function. I. Restricted 
heterogeneity of the antibody response of B lymphocytes from neonatal and fetal  mice. dr. 
Exp.  Med. 140:1285. 
45.  Marshall-Clarke, S., and J.  H.  L.  Playfair.  1978. Age dependent changes in the relative 
affinity of anti-dinitrophenyl  antibodies in mice. Immunology. 29:477. 
46.  Gearhart, P. J., N. H. Sigal, and N. R. Klinman. 1977. The monoclonal anti-phosphoryl- 
choline antibody response  in  several  murine strains:  genetic  implications of a  diverse 
repertoire.,]. Exp.  Med. 145:876. 
47.  Cancro, M. P., D. E. Wylie, W. Gerhard, and N. R. Klinman. 1978. Differential expression 
of an equivalent clonotype among BALB/c and C57BL/6 mice. dr. Exp.  Med. 147:1. 
48.  Gearhart,  P. J.,  and J. j.  Cebra.  1978. Idiotype sharing by murine strains differing in 
immunoglobulin  allotype. Nature (Lond).  272:264. 
49.  Ju, S.-T., T. J. Kipps, J. Theze, B. Benacerraf, and M. E. Dorf.  1978. Idiotypic analysis of 
anti-GAT antibodies. I. Presence of common idiotypic specificities  in both responder and 
non-responder mice. J. Immunol. 121:1034. 
50.  Sachs,  D.  H.  1980. Genetic control  of  idiotype  expression.  In  Immunology  1980. M. 
Fougereaux and J. Dausset, editors.  Academic Press Inc., London. 478-495. 
51.  Cancro,  M.  P.,  and  N.  R.  Klinman.  1981.  B  cell  repertoire  ontogeny:  heritable  but 
dissimilar development of parental and Fl repertoires, dr. hnmunol. 126:1160. KATHLEEN  A.  DENIS AND NORMAN  R.  KLINMAN  1183 
52.  Stashenko,  P.,  and  N.  R.  Klinman.  1980. Analysis of the  primary anti-(4-hydroxy-3- 
nitrophenyl) acetyl  (NP)  responsive B  cells  in  BALB/c  and  B10.D2  mice. J.  Immunol. 
125;531. 
53.  Potter, M.  1981. Structures of idiotypes.J. Supramolec. Struct. 5-'2. 
54.  Laskin, J. A., A. Gray, A. Nisonoff,  N. R. Klinman, and P. D. Gottlieb. 1977. Segregation 
at  a  locus determining an immunoglobulin genetic marker for the light chain variable 
region affects  inheritance of expression of an idiotype. Proc. Natl.  Acad. Sci. USA.  74"-4600. 
55.  Ju, S.-T., A. Gray, and A. Nisonoff.  1977. Frequency of occurrence of idiotypes associated 
with anti-p-azophenylarsonate  antibodies arising in mice immunologically  suppressed with 
respect  to a cross-reactive idiotype.J. Exp. Med.  145:540. 